Iovance Biotherapeutics Unusual Options Activity For February 22

Financial giants have made a conspicuous bullish move on Iovance Biotherapeutics. Our analysis of options history for Iovance Biotherapeutics IOVA revealed 23 unusual trades.

Delving into the details, we found 56% of traders were bullish, while 43% showed bearish tendencies. Out of all the trades we spotted, 3 were puts, with a value of $128,675, and 20 were calls, valued at $1,235,224.

Predicted Price Range

After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $5.0 and $22.0 for Iovance Biotherapeutics, spanning the last three months.

Volume & Open Interest Development

Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Iovance Biotherapeutics's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Iovance Biotherapeutics's whale trades within a strike price range from $5.0 to $22.0 in the last 30 days.

Iovance Biotherapeutics Option Activity Analysis: Last 30 Days

Biggest Options Spotted:

About Iovance Biotherapeutics

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approval and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

After a thorough review of the options trading surrounding Iovance Biotherapeutics, we move to examine the company in more detail. This includes an assessment of its current market status and performance.

Present Market Standing of Iovance Biotherapeutics

• With a trading volume of 14,434,997, the price of IOVA is up by 3.49%, reaching $16.32.
• Current RSI values indicate that the stock is may be overbought.
• Next earnings report is scheduled for 12 days from now.

Professional Analyst Ratings for Iovance Biotherapeutics

Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $22.4.

• An analyst from Goldman Sachs has decided to maintain their Buy rating on Iovance Biotherapeutics, which currently sits at a price target of $19.
• Maintaining their stance, an analyst from Goldman Sachs continues to hold a Buy rating for Iovance Biotherapeutics, targeting a price of $19.
• An analyst from Piper Sandler has decided to maintain their Overweight rating on Iovance Biotherapeutics, which currently sits at a price target of $18.
• Maintaining their stance, an analyst from Wells Fargo continues to hold a Overweight rating for Iovance Biotherapeutics, targeting a price of $22.
• An analyst from Chardan Capital persists with their Buy rating on Iovance Biotherapeutics, maintaining a target price of $34.

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Iovance Biotherapeutics options trades with real-time alerts from Benzinga Pro.